Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The ...

Could GLP-1 receptor agonists (GLP-1RAs), already used in obesity and diabetes, be repurposed as drugs to slow aging? Hong ...

A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc., have been approved by the U.S. FDA. Hyrnuo (sevabertinib), a reversible ...

Tempest Therapeutics Inc. entered definitive agreements approved by its board to acquire certain dual-targeting CAR T ...

Success in Japan may further bolster Protara Therapeutics Inc. in its push with TARA-002 in pediatric patients with ...

In a verbal sparring over who can deliver the lowest drug prices in the U.S., several Senate Democrats are urging President ...

Med-tech M&A activity cooled in October, with the total disclosed deal value reaching $1.68 billion, a step down from ...

U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, ...

The limited efficacy of cancer immunotherapy is usually attributed to suboptimal antitumor T-cell generation, as well as ...

Radiopharm Theranostics Ltd. has been granted Bellberry Human Research Ethics Committee (HREC) approval in Australia to ...

The European Commission posted a series of proposed legislative updates, including the AI Act, which might not come into ...

Mabloc LLC has established a strategic partnership with Instituto Butantan to co-develop and manufacture MBL-YFV-01, a ...